Global Ganja Report

Turned down by the British government when they requested permission to use cannabis oil, the family of a child epilepsy sufferer personally delivered a petition with thousands of signatures to 10 Downing Street. They were backed up by members of parliament and the famous actor Sir Patrick Stewart. Charges of hypocrisy on the part of government were brought into sharp focus by revelations that the Home Office minister—ultimately responsible for the decision to turn down the request—is married to a businessman who oversees massive cultivation under contract to GW Pharmaceuticals.

A British Columbia firm which is one of Canada's leading licensed producers of medical marijuana has entered a partnership with the national subsidiary of Sandoz, a global leader in the pharmaceutical industry. The deal is being hailed as a milestone that signals the arrival of cannabis in the corporate economy.

Several bills now pending before the Colorado state house will further shape what the legal cannabis economy will look like in the Centennial State—for better or for worse. While some of these measures would mean a freer atmosphere both for "recreational" and medicinal users, others may portend greater big-money control of the fast-growing industry.

Amid legal challenges and disputes over zoning in Detroit, Michigan's long-awaited regulatory regime for cannabis dispensaries continues to face obstacles to implementation. This has left hundreds of dispensaries operating in a "gray market"—tolerated by the authorities on an unofficial basis while the mess is being worked out. But now state authorities have started to order these outlets closed—potentially leaving thousands of registered users without access to their medicine.

Seniors are the fastest growing group of medicinal cannabis users in the country, and a growing number of nursing homes from coast to coast are tolerating use of tinctures and extracts to combat dementia, insomnia and related ailments. Patient testimony is now backed up by research, with scientists identifying the mechanism by which cannabinoids slow the deterioration of neurons in the brain. But federal strictures continue to pose an obstacle to investigation—leaving medicinal users in the cold under US law.

Another dispensary is raided by police in Toronto—the latest in a string of such busts in the city over the past months, with some outlets even shut down. It's an irony that this crackdown comes as Canada is in its final countdown to legalization, and opens questions about whether there will be a place for independent dispensaries and small growers under the imminent new regulation regime.

Oakland's city council has passed an ordinance protecting tenants from being evicted by cannabis businesses in the city's "Green Zone." Artist housing in post-industrial areas is especially at risk. Oakland is committed to a policy of "cannabis equity," in which the cannabis economy is daylighted with a sense of social justice. But this does point to the dilemma of cannabis-fueled displacement—a phenomenon also reported from places like the more freewheeling Denver, which are less committed to principles of equity.

Oakland-based cannabis industry research firm ArcView Group has released a new study, ambitiously entitled "The Road Map to a $57 Billion Worldwide Market." It provides a sweeping overview of recent progress and future prospects for legal or medical herb across the globe. But it also warns that, due to continued legal restrictions and bureaucratic overstretch, the market is in most areas bottlenecked from achieving its potential.